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Compared to lower metazoans, vertebrates built up an exclusively new set of adhesion-related genes involved in the tissue
development and in their functions. They include a large variety of extracellular matrix proteins and their heterodimeric integrin
adhesive receptors. Integrins control the adhesive state of the cell through complex molecular mechanisms. Outside-in
signalling informs the cell about the extracellular matrix environment, while Inside-out signalling results in changes in integrin
functional activity. In the last 10 years it has well established a reciprocal integration of signals originating from integrins and
receptors for soluble growth factors. This review summarizes the current understanding of this connection in vascular
endothelial cells and highlights how integrins regulate a genetic program triggered by angiogenic inducers during embryo
development and in adult life.
© 2007 Elsevier B.V. All rights reserved.
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The generation of a vascular system hierarchically
organized into arteries, capillaries, and veins allows the
19L. Napione et al. / Autoimmunity Reviews 7 (2007) 18–22efficient transport of oxygen and nutrients to the tissues
so that they can growth, develop, and function. The
complexity of these mechanisms occurring in embry-
onic and adult life is de-regulated in pathological
settings including cancer, chronic inflammatory dis-
eases, and retinopathies. In these conditions vasculature
is highly chaotic and inefficient, mainly due to an
unbalance between activating and inhibiting cues
targeting vascular cells.
Five biological phases of angiogenesis have been
established and characterized by different, overlapping
genetic programs. Initiation is characterized by an
endothelial cell (EC) shape change and increased
permeability; progression phase includes the degradation
of extracellular matrix, migration and proliferation of
ECs; in the differentiation phase ECs stop to growth,
survive in sub-optimal conditions, and differentiate into
primitive capillaries; maturation phase includes the
formation of new matrix and the recruitment of pericytes;
remodeling phase generates the mature and hierarchically
shaped vascular bed and required regression of some
vessels by apotosis and pruning and branching of others
[1]. Besides several soluble factors (PDGFs, TGFs, FGFs,
HGF, chemokines, autacoids, cytokines), which appear to
have a relevant but redundant role, the above steps are
largely regulated by molecules with a high specificity for
the vascular system: the family of vascular endothelium
growth factors (VEGF) and their tyrosine kinase receptors
(TKR), VEGFR-1, -2, and -3, and the family of
angiopoietins (Ang) and Tie-2 TKR [2,3].
It appears that all through the angiogenic process
blood vessel ECs undergo collective movements
regulated by several guidance cues that dynamically
modulate their cell-to-cell and cell-to-extracellular
matrix (ECM) adhesive contacts [4]. During tissue
morphogenesis, while cell-to-cell interactions maintain
the cohesion of multicellular structures, the finely tuned
regulation of cell adhesion to the ECM controls the
direction of collective cell motility. Integrin αβ
heterodimers are major ECM receptors that exist in
different functional conformations with regard to their
affinity for ligands [5] and play key roles in embryonic
and post-natal angiogenesis [4].
In this review we will summarize data indicating that
different integrins modulate the activity of VEGF
receptors and Tie-2 resulting in an additional control
of EC functions during angiogenesis.
2. Integrin-dependent modulation of VEGFRs
During angiogenesis, ECs adhere to a provisional
ECM through αvβ3 integrin. Once engaged withvitronection or fibrin, this integrin participates in a
complex containing VEGFR-2 and PI 3-kinase [6–8].
The impact of the integrin pair on this complex is
illustrated by studies performed with an anti-β 3
antibody that interferes with αvβ3 clustering but not
with cell adhesion to the ECM. Not only does the
antibody perturb the formation of this complex, but it
also markedly inhibits VEGFR-2-mediated phosphory-
lation, PI 3-kinase activity, focal adhesion dynamics as
well as the proliferation and migration of ECs triggered
by VEGF-A [6]. In contrast, αvβ3 clustering is
permissive for VEGFR-2 activation and an optimal
response of ECs to VEGF-A [6,8,9]. Formation of the
VEGFR-2/ αvβ3 complex requires the extracellular
domain and the Y phosphorylation sites in the cytosol
tail of β3 integrin [7,8]. Because VEGF-A induces Y
phosphorylation of β3 subunit though VEGFR-2
resulting in inside-out integrin activation [7,8,10], it is
evident that that these two receptors are able to
crossactivate each other, therefore forming a functional
partnership that is essential for successful angiogenesis.
The key role of VEGFR-2/αvβ3 integrin complex
has been further envisaged by the elucidation of the
angiogenic effect of Factor XIII (FXIII), the transglu-
taminase that participates at the final step of the
coagulation cascade. Activated FXIII crosslinks β3
integrin to VEGFR-2 as well as enhances the non-
covalent complex formation between the β3 integrin
and VEGFR-2. In this complex VEGFR-2 results to be
activated in a VEGF-A — independent manner but
requires both the tranglutaminase and TK activities of
FXIII and VEGFR-2 [11].
In contrast to αvβ3/vitronectin (or fibrin) pair, which
shows a permissive effect on VEGFR-2 phosphoryla-
tion, collagen I, the ligand of α1β3 and α2β1 integrins,
exerts an inhibitory action on this TKR [12]. EC
adhesion to collagen I reduces VEGF-A-induced
VEGFR-2 autophosphorylation by recruiting the tyro-
sine phosphatase SHP2 to the pY117 of cytosolic tail of
the receptor. The interaction of SHP2 to VEGFR-2 is
strictly dependent on EC adhesion to collagen I and not
to other ECM proteins. The more pronounced VEGFR-2
dephosphorylation is connected with a higher degree of
its internalization. The down-regulation of VEGFR-2 by
SHP2 could be considered a simpler and faster way to
modify its behaviour and functions as compared to
clathrin-mediated or caveolae-dependent endocytosis or
to proteasome-mediated degradation [2]. The effect of
collagen I to limit VEGFR-2 parallels the effect TIMP-
2, which negatively regulates VEGFR-2 by SHP1
activation [13]. In ECs stimulated with TIMP-2, SHP1
shifts from α3β1 integrin to VEGFR-2, which is
Fig. 1. Integrin 5β1 modulates Tie-2 activity. (A) Free-Tie-2 responds to
high Ang-1 concentrations with transient activation. (B) Integrin 5β1
activated by fibronectin forms a complex with Tie-2, which in turn
responds to a low Ang-1 concentration for long-lasting time; Tie-2
stimulation supports an integrin inside-out signal. (C) The signal coming
from 5β1/Tie-2 complex is further reinforced by a direct 5β1 integrin
stimulation byAng-1. This dual stimulation results in a combined activity
of inside-out and outside-in signals (for details see text).
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outcome. Similarly α1β1 integrin engaged by collagen
activates the T-cell protein tyrosine phosphatase func-
tion that inhibits EGF receptor signalling [14]. It has
been reported that in vascular smooth muscle cells β3
engagement by vitronectin results in tyrosine phosphor-
ylation of its cytosolic domain and recruitment of SHP2,
which modulates insulin growth factor I receptor[15].
Thus, we hypothesize a protective role on VEGFR-2
signalling by vitronectin-engaged αvβ3, which recruits
SHP2 and preserves the receptor from phosphatase
activity. In contrast EC adhesion on collagen I, which
does not dependent on αvβ3 integrin, could allow SHP2
interacting with VEGFR-2.
The modulatory role of integrins on VEGFRs is not
restricted to the type 2. VEGFR-3 stimulated by VEGF-
C or VEGF-D plays a major role in lymphangiogenesis.
It has been demonstrated that VEGF-C – stimulated
VEGFR-3 selectively associates with α5β1. Integrin
α5β1 ligation by fibronectin is required for the optimal
activation of VEGFR-3 signalling not only at the
receptor level but also at its downstream effectors [16].
3. α5β1 integrin sustains Tie-2 activation
The angiopoietin family and its TKR Tie-2 have
primary roles in the latter stages of angiogenesis where
they control remodelling and stabilization of vessels.
Ang-1 is required for correct organization and matura-
tion of newly formed vessels, and promotes quiescence
and structural integrity of adult vasculature [3].
We have recently reported that in ECs, Tie-2 is present
in free-form and associated with α5β1 integrin (Fig. 1,
A, B). The activation of α5β1 integrin by fibronectin
increases the complex with Tie-2 and modulates the time
and concentration window of the receptor activation.
When α5β1 is activated, Tie-2 is phosphorylated at
lower Ang-1 concentrations than those required on other
ECM proteins. Furthermore, α5β1/Tie-2 complex
allows the TKR stimulation prolonged up to a hour,
while the signal of free Tie-2 is more transient.
Therefore, it seems that α5β1 activation could influence
Tie-2 signal duration and signal strength. Ang-1 does not
modify the features of association between Tie-2 and
fibronectin-engaged α5β1, but triggers biochemical
signals that recruit p85 and focal adhesion kinase
(FAK) to the complex. It is known that p85 binds
activated Tie-2 [3], whereas FAK is recruited to the
cytosolic tail of clusterized integrins at the focal
adhesions [4]. Thus, Ang-1 stimulation mediates Tie-2
and α5β1 signalling, and allows a cross-talk between
these pathways by acting at the level of Tie-2/α5β1complex. We demonstrated that Ang-1/Tie-2 activates
integrins through the PI3-kinase signalling, which
suggests that FAK recruitment to Tie-2/5β1 complex
could be dependent on activated Tie-2 inside-out
21L. Napione et al. / Autoimmunity Reviews 7 (2007) 18–22signalling. Conversely, the observation that immobilized
[17] or soluble Ang-1 binds and activates α5β1 in the
absence of Tie-2 demonstrates that Ang-1 promotes
α5β1 outside-in signalling. All together the results
suggest a model in which the synergism of Tie-2/α5β1
inside-out/outside-in signalling would allow the stabili-
zation of the complex and the activation of Tie-2 at lower
Ang-1 concentrations (Fig. 1C).
4. Concluding remarks
Substantial evidence suggests that signalling is a
compartmentalized event. Here we reported some
examples describing how integrin adhesive receptors
form supramolecular complexes with TKR in ECs
localized at adhesive sites and influence the cell
response to angiogenic inducers. These complexes
described in ECs may represent a general strategy that
contributes to the relative complexity of some species,
including humans, compared to other organisms. Rather
than using a larger number of genes to achieve a greater
level of biological complexity higher organisms have
evolved more intricate biochemical architectures, which
are built from a relatively limited number of proteins.
Future experiments will be required to understand how
TKR/integrin complexes participate in EC differentia-
tion during development and their behaviour in
pathological angiogenesis.
Acknowledgements
Supported by Telethon Italy— grant no. GGP04127,
Sixth Framework Programme of European Union
Contract LSHM-CT-2003-503254, the “Associazione
Italiana per la Ricerca sul Cancro”, “Regione Piemonte”,
“M.I.U.R” and “Ministero della Salute”.Take-home messages
• Angiogenesis, a critical component of neoplastic and
chronic inflammatory disorders, depends on the
cooperation of growth factors and cell adhesion
events.
• Integrin adhesive receptors form supramolecular
complexes with TKRs in endothelial cell influencing
cells response to angiogenic factors and blood vessel
permeability.
• The formation of VEGFR2/αvβ3 complex is per-
missive for an optimal TKRs activation, while
clustering and activation of other integrin, such as
α1β3 and α2β3, exerts an inhibitory action onVEGFR2 by recruiting the tyrosine phosphatase
SHP2.
• Ang-1binds and activates both Tie-2 and α5β1
allowing a synergism their inside-out/outside-in
signalling.
• α5β1/Tie-2 complex stabilizes and extends the signal
induced by Ang-1 compared to that of Tie-2 alone.
• Also lymph angiogenesis, an important process
involved in several normal and pathological condi-
tions such as wound healing, inflammation or
metastasis formation in several malignancies, can
be modulated by integrins recruitment. Indeed α5/β1
binds and modulates VEGFR3.
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